US 2020/0246286 A1 · NOVEL IMAGING COMPOSITION AND USES THEREOF

Abstract

The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.

Claims1

Dependent claims

A radionuclide complex of a compound of formula (I):

or a pharmaceutically acceptable salt thereof, wherein L is a leaving group.

Dependencies are inferred from the claim text.

Facts

Application

16/843,215Filed 8 Apr 2020

Priority

AU 201490413816 Oct 2014

Published

6 Aug 2020

Term ends

Not estimatedThe source records don’t support an estimate.

Classification34 codes

A61K 31/18
Amides, e.g. hydroxamic acids: sulfonamides
A61K 51/1051
Against animal or human tumor cells or tumor cell determinants: the tumor cell being from breast, e.g. the antibody being herceptin
C07C 259/06
Without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids: having carbon atoms of hydroxamic groups bound to…
C07C 309/14
Containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton: containing amino groups bound to the carbon…

Family

Application15/518,333Continuation · filed 11 Apr 2017

Application15/963,599Continuation · filed 26 Apr 2018

Application16/511,577Continuation · filed 15 Jul 2019

Application16/843,215Continuation

US 10,398,660 B2Related patent

US 10,653,649 B2Related patent

US 11,123,316 B2Related patent

US 2017/0326084 A1Published application

US 2019/0099392 A1Published application

US 2020/0009090 A1Published application

US 9,980,930 B2Related patent

US 2020/0246286 A1This patent

From the US filing history. Foreign family members aren’t listed.